Ppd Inc (PPD) Return on Investment ROI from the third quarter of 2021 to third quarter of 2020 and for the year 2021, average high and low, overall ranking from Sep 30 2021 to Sep 30 2020 - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Ppd Inc   (NASDAQ: PPD)
    Sector • Healthcare    Industry • Medical Laboratories
   Industry • Medical Laboratories
   Sector • Healthcare


Ppd Inc's ROI from its third quarter of 2021 to the third quarter of 2020 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Ppd Inc's ROI in the third quarter of 2021?
Ppd Inc achieved a return on average invested assets (ROI) of 9.91 % in its third quarter of 2021, this is above PPD's average return on investment of 4.86%.
Ppd Inc s investments during the 12 months ending in the third quarter of 2021 are valued at $3 billion

ROI has improved compared to 4.48% in the second quarter of 2021, due to net income growth.

Within the Healthcare sector 124 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the second quarter of 2021 from 0 to 1258.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Sep 30 2021)
III. Quarter		 (Jun 30 2021)
II. Quarter		 (Mar 31 2021)
I. Quarter		 (Dec 31 2020)
IV. Quarter		 (Sep 30 2020)
III. Quarter
Y / Y Investment Change TTM -53.38 % -42.75 % -10.26 % 53.19 % 280.1 %
Y / Y Net Income Change TTM 537.56 % 220.81 % 6283.94 % 868.25 % 250.34 %
Investment (TTM) in Millions 3,881 3,767 3,672 3,632 7,708
Return On Investment (TTM) 9.91 % 4.48 % 3.91 % 2.4 % 0.72 %
PPD's Overall Ranking # 1258 # 0 # 0 # 0 #
Seq. Investment Change TTM -20.38 % -16.96 % -15.33 % -16.73 % -2.23 %
Seq. Net Income Change TTM 76.06 % -4.82 % 37.65 % 176.38 % -11.41 %
Net Income (TTM) in Millions 370 210 221 161 58

PPD Company Profile >> Back to PPD Roi Comparisons >> See Annual PPD Return On Investment



Return On Investment PPD's Ranking
Within: No.
Industry # 10
Sector # 125
Overall # 1258

Return On Investment Statistics
High Average Low
9.06 %
4.86 %
2.37 %
(Sep 30 2021)   (Dec 31 2020)







Financial Statements
Ppd Inc's III. Quarter Investments $ 3,881 Millions PPD's Balance sheet
Ppd Inc's III. Quarter Income $ 169 Millions Quarterly PPD's Income Statement
PPD's Income by Division See PPD's Income by Division


PPD Annual Return On Investment (Dec 31 2020)
2020



Total Investments in Millions 3,632 0 0 0 0
Y / Y Investment Growth - - - - -
Net Income in Millions 161 0 0 0 0
Y / Y Net Income Growth - - - - -
Annual Return On Investment 4.42 % - - - -


Annual Roi Comment
In the fiscal year 2020 ROI deteriorated to 4.42 %, despite net income growth.

Definition and Formula of Return on Investment

Other ROI Ratios
Medical Laboratories Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
PPD's Roi Ratio versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for PPD's Competitors
Subscribers only: Roi for Ppd Inc's Suppliers
Subscribers only: Return On Investment for PPD's Customers

Other Ratios
PPD's Roa PPD's Inventory Turnover Ratio PPD's Growth Rates PPD's Dividend Statistics
PPD's Profitability Ratios PPD's Asset Turnover Ratio PPD's Dividend Growth
PPD's Roe PPD's Valuation Ratios PPD's Financial Strength Ratios PPD's Dividend Payout Ratio



Companies with similar Return On Investment at Sep 30 2021, within Healthcare Sector ROI
Neurocrine Biosciences Inc   26.67 %
Hologic Inc  26.27 %
Chemed Corporation  26.20 %
West Pharmaceutical Services Inc   25.54 %
Tivity Health Inc   25.10 %
Elite Pharmaceuticals Inc   24.48 %
Encision Inc   23.71 %
Dyadic International Inc   23.56 %
Vaso Corporation  23.38 %
Collegium Pharmaceutical Inc   23.26 %
Edwards Lifesciences Corporation  22.41 %
Sana Biotechnology Inc   22.32 %
Catalyst Pharmaceuticals Inc   22.25 %
Organogenesis Holdings Inc   22.02 %
Vertex Pharmaceuticals Inc  21.16 %
Corcept Therapeutics Inc  20.28 %
Align Technology inc   20.16 %
Waters Corporation  18.90 %
Quest Diagnostics Inc  18.24 %
Amedisys Inc  18.07 %
Meridian Bioscience Inc   17.93 %
Lftd Partners Inc   17.65 %
Procyon Corporation  17.44 %
Eli Lilly And Company  17.40 %
Crispr Therapeutics Ag  17.16 %
Pro dex Inc   17.05 %
Biodelivery Sciences International Inc   16.86 %
Incyte Corporation  16.85 %
Prothena Corporation Public Limited Company  16.83 %
Atrion Corporation  16.54 %

Date modified: 2026-09-08T15:10:23+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.